- The team was led by KAM's Chief Executive Officer Anthony Mwangi.
Kenya’s plan to ensure sustainability in the local manufacturing of health products is gaining momentum.
This is after the Kenya Association of Manufacturers met with the health PS Josephine Mburu to implore possible Public Private Partnerships in achieving this goal.
Mburu met with representatives from the association on Tuesday to discuss ways to enhance local manufacturing of pharmaceuticals for both domestic use and export.
The team was led by KAM's Chief Executive Officer Anthony Mwangi.
“The discussion focused on cooperation between KAM and the government to improve Kenya's global competitiveness in manufacturing Health Products and Technologies (HPTs),” the ministry said in a statement.
This comes barely a week after the government of the Netherlands committed to supporting Kenya’s plan to have local manufacturing of essential health products among other development projects.
This emerged in a meeting that took place between the Netherlands Ambassador Maarten Brouwer and the Health CS Susan Wafula on Thursday.
Kenya and the Netherlands have shared a longstanding diplomatic relationship that has resulted in various development projects over the years.
Kenya formally presented her letter of intent to join the International Vaccine Institute as a state party in Seul, South Korea in November 2022.
The letter was presented by Foreign Affairs CS Alfred Mutua and witnessed by President William Ruto and CS Wafula.
The Kenya Biovax Institute, a state cooperation mandated with the manufacturing of specialised health products including vaccines and therapeutics is set to kick-start the manufacturing process in earnest.
Kenya is preparing to set up a Moderna manufacturing facility in the country, the first in Africa to produce messenger RNA (mRNA) vaccines, including Covid-19 shots.